Correlation Between FibroBiologics, Common and ReTo Eco

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FibroBiologics, Common and ReTo Eco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroBiologics, Common and ReTo Eco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroBiologics, Common Stock and ReTo Eco Solutions, you can compare the effects of market volatilities on FibroBiologics, Common and ReTo Eco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroBiologics, Common with a short position of ReTo Eco. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroBiologics, Common and ReTo Eco.

Diversification Opportunities for FibroBiologics, Common and ReTo Eco

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between FibroBiologics, and ReTo is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding FibroBiologics, Common Stock and ReTo Eco Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReTo Eco Solutions and FibroBiologics, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroBiologics, Common Stock are associated (or correlated) with ReTo Eco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReTo Eco Solutions has no effect on the direction of FibroBiologics, Common i.e., FibroBiologics, Common and ReTo Eco go up and down completely randomly.

Pair Corralation between FibroBiologics, Common and ReTo Eco

Given the investment horizon of 90 days FibroBiologics, Common Stock is expected to under-perform the ReTo Eco. But the stock apears to be less risky and, when comparing its historical volatility, FibroBiologics, Common Stock is 3.55 times less risky than ReTo Eco. The stock trades about -0.04 of its potential returns per unit of risk. The ReTo Eco Solutions is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  4,620  in ReTo Eco Solutions on September 19, 2024 and sell it today you would lose (4,522) from holding ReTo Eco Solutions or give up 97.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy46.95%
ValuesDaily Returns

FibroBiologics, Common Stock  vs.  ReTo Eco Solutions

 Performance 
       Timeline  
FibroBiologics, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FibroBiologics, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
ReTo Eco Solutions 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ReTo Eco Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

FibroBiologics, Common and ReTo Eco Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FibroBiologics, Common and ReTo Eco

The main advantage of trading using opposite FibroBiologics, Common and ReTo Eco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroBiologics, Common position performs unexpectedly, ReTo Eco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReTo Eco will offset losses from the drop in ReTo Eco's long position.
The idea behind FibroBiologics, Common Stock and ReTo Eco Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences